Thirty-month follow-up of coronary artery calcification in hemodialysis patients: Different roles for inflammation and abnormal calcium-phosphorous metabolism?

Renal Failure

Volumn 29, Issue 5, 2007, Pages 623-629

  Patsalas, Stavros ^a   Eleftheriadis, Theodoros ^a,c   Spaia, Sofia ^a   Theodoroglou, Hariklia ^a   Antoniadi, Georgia ^a   Liakopoulos, Vassilis ^b   Passadakis, Ploumis ^b   Vayonas, Georgios ^a   Vargemezis, Vassilis ^b  

^a 2nd IKA Hospital   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c PC 54645 ^*  (Greece)

Author keywords

Coronary calcification; Hemodialysis; Inflammation; Phosphorous

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CALCIUM PHOSPHATE; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; AGING; ARTERY CALCIFICATION; ARTICLE; CALCIUM INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; INFLAMMATION; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; TREATMENT DURATION;

CALCINOSIS; CALCIUM METABOLISM DISORDERS; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PHOSPHORUS METABOLISM DISORDERS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 34547165670     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701395010     Document Type: Article

References (24)

1. US Renal Data System. USRDS 1997 Annual Data Report. Bethesda, Md.: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1997.
2. US Department of Health and Human Services. Morbidity and Mortality: Chartbook on Cardiovascular, Lung and Blood Disease. Bethesda, Md.: US Department of Health and Human Services; 1996.
3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl. 3):S112-S119.
4. He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation. 2000;101:244-251.
5. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394-401.
6. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
7. Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant. 2004;19(9):2307-2312.
8. Sharples EJ, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis. 2004; 43:313-319.
9. Patsalas S, Eleftheriadis T, Spaia S, et al. The value of computed tomography-derived coronary artery calcification score in coronary artery disease detection in asymptomatic hemodialysis patients. Ren Fail. 2005;27(6): 683-688.
10. Tamashiro M, Iseki K, Sunagawa O, et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis. 2001;38(1):64-69.
11. Chertow GM, Burke SK, Raggi P. Treat to goal working group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245-252.
12. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39(4):695-701.
13. Barreto DV, Barreto FC, Carvalho AB, et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005;67(4):1576-1582.
14. Asmus HG, Braun J, Krause R, et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant. 2005;20(8):1653-1661.
15. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on hemodialysis. Nephrol Dial Transplant. 2006;21(7):1915-1920.
16. Galassi A, Spiegel DM, Bellasi A, Block GA, Raggi P. Accelerated vascular calcification and relative hypoparathyroidism in incident hemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transplant. 2006;21(11):3215-3222.
17. Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcification and atherosclerosis in maintenance hemodialysis patients. Nephrol Dial Transplant. 2007;22(2):515-521.
18. Becker CR, Knez A, Jakobs TF, et al. Detection and quantification of coronary artery calcification with electron-beam and conventional CT. Eur Radiol. 1999;9:620-624.
19. Becker CR, Jakobs TF, Aydemir S, et al. Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification. Am J Radiol. 2000;174:543-547.
20. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
21. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363-369.
22. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-658.
23. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361(9360):827-833.
24. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112(3):357-366.